Skip to content
AnalystLens

Elevance Health, Inc. Annual Report, Year Ended Dec 31, 2004

Filing Date
Filed March 14, 2005
Period End
December 31, 2004
Security
ELV
In the record · 2016–202610-K1110-Q348-K133

ELV filed 11 annual reports (10-K), 34 quarterly reports (10-Q) and 133 current reports (8-K) between 2016 and 2026.

  1. FY2016 annual report10-K · Feb ’17Feb ’17
  2. Leadership change8-K · Oct ’19Oct ’19
  3. Deal closed8-K · Apr ’22Apr ’22
  4. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 10-K filed March 14, 2005. Cited figures are marked; the original filing is the authoritative source.

Elevance Health, Inc. (formerly WellPoint, Inc. after the November 30, 2004 merger of Anthem and WellPoint Health Networks Inc.) reported strong performance for the fiscal year ending December 31, 2004.

The significant merger, valued at approximately $16 billiona, has positioned the company as the largest publicly traded commercial health benefits provider in the U.S. by membership, serving over 27 million members. The company experienced substantial revenue growth driven by both organic membership increases across various customer segments like National Accounts and Individual/Small Group, and the inclusion of acquired businesses. Financially, the company demonstrated robust growth in premiums and administrative fees, reflecting the expanded scale and market reach post-merger.

Despite increased benefit expenses due to higher costs in outpatient and pharmacy services, as well as the integration of new members, the company managed its selling, general, and administrative expenses effectively, leading to a significant increase in operating gain. The company's balance sheet remains strong, with substantial cash and investments, and a manageable debt-to-total capital ratio, indicating a solid financial foundation for future growth and strategic initiatives.

Key Highlights

  1. Completed a transformative merger with WellPoint Health Networks Inc. on November 30, 2004, creating the largest publicly traded commercial health benefits company by membership in the U.S., serving over 27 million members.
  2. Achieved significant growth in total operating revenue, up 24% to $20.46 billion, driven by premium increases and membership growth across key segments.
  3. Reported a 24% increase in net income to $960.1 million, with diluted earnings per share rising to $6.10.
  4. Demonstrated effective cost management, with a decrease in the SG&A expense ratio to 17.0%, despite increased benefit expenses.
  5. Maintained a strong balance sheet with $15.8 billion in cash and investments and a debt-to-total capital ratio of 18.5% at year-end.
  6. Expanded medical membership by 6% to 27.7 million members, with notable growth in National Accounts and Individual/Small Group segments.
  7. Actively managed its investment portfolio, with approximately 91% in debt securities and an average credit rating of AA for its corporate fixed maturity portfolio.

Frequently Asked Questions

  1. What was the primary strategic event for Elevance Health (WellPoint) in 2004?

    The most significant strategic event was the completion of the merger with WellPoint Health Networks Inc. on November 30, 2004. This transaction created a significantly larger entity, positioning it as the largest publicly traded commercial health benefits company in the U.S. by membership, serving over 27 million members.

  2. How did the merger impact the company's financial performance in 2004?

    The merger led to a substantial increase in operating revenue, up 24% to $20.46 billion, and a corresponding 24% increase in net income to $960.1 million. This growth was driven by the combined entities' membership and revenue streams, although benefit expenses also increased due to the expanded member base and higher cost of care.

  3. What is the company's approach to managing costs and ensuring profitability?

    The company focuses on effective cost management, as evidenced by a decrease in the SG&A expense ratio to 17.0%. They employ medical management programs, negotiate provider contracts, and leverage their scale for economies. While benefit expenses rose, the company aims to offset these through operational efficiencies and premium rate adjustments where appropriate.

  4. What is the company's financial health and outlook based on this filing?

    The company appears to be in strong financial health, with a substantial cash and investment balance of $15.8 billion and a manageable debt-to-total capital ratio of 18.5%. The significant membership growth and revenue increase post-merger, combined with effective cost control, suggest a positive outlook for future performance, though managing rising healthcare costs remains a key operational focus.